Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioXcel Therapeutics (BTAI) Current Taxes (2022 - 2025)

BioXcel Therapeutics (BTAI) has 4 years of Current Taxes data on record, last reported at $103000.0 in Q3 2025.

  • For Q3 2025, Current Taxes rose 45.07% year-over-year to $103000.0; the TTM value through Sep 2025 reached $103000.0, up 45.07%, while the annual FY2024 figure was $91000.0, 21.55% down from the prior year.
  • Current Taxes reached $103000.0 in Q3 2025 per BTAI's latest filing, down from $108000.0 in the prior quarter.
  • Across five years, Current Taxes topped out at $529000.0 in Q3 2022 and bottomed at $65000.0 in Q1 2025.
  • Average Current Taxes over 4 years is $162200.0, with a median of $108000.0 recorded in 2025.
  • Peak YoY movement for Current Taxes: tumbled 74.86% in 2023, then soared 54.29% in 2025.
  • A 4-year view of Current Taxes shows it stood at $82000.0 in 2022, then skyrocketed by 41.46% to $116000.0 in 2023, then fell by 21.55% to $91000.0 in 2024, then grew by 13.19% to $103000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Current Taxes were $103000.0 in Q3 2025, $108000.0 in Q2 2025, and $65000.0 in Q1 2025.